N-arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B

Bioorg Med Chem Lett. 2003 Nov 17;13(22):4121-4. doi: 10.1016/j.bmcl.2003.08.006.

Abstract

To improve the pharmacokinetics of a previously reported series of dipeptidyl nitrile cathepsin B inhibitors, the P(2)-P(3) amide group was replaced with an arylamine. Further optimization of this template resulted in highly potent and selective inhibitors with excellent oral availability.

MeSH terms

  • Administration, Oral
  • Animals
  • Biological Availability
  • Cathepsin B / antagonists & inhibitors*
  • Dipeptides / administration & dosage
  • Dipeptides / chemical synthesis
  • Dipeptides / pharmacokinetics*
  • Dipeptides / pharmacology
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / pharmacokinetics*
  • Enzyme Inhibitors / pharmacology
  • Models, Molecular
  • Molecular Conformation
  • Rats
  • X-Ray Diffraction

Substances

  • Dipeptides
  • Enzyme Inhibitors
  • Cathepsin B